Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
14% from low
Exchange
OTC Link
CS
SOHM INC
No one on the platform currently holds SHMN.
No tracked institution reports a position in SHMN as of their last filing.
No one on the platform has traded SHMN yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$SHMN https://www.newswire.com/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology
View on StockTwits ↗$SHMN This will come into play on SHMN sooner or later https://www.newswire.com/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology
View on StockTwits ↗$SHMN SHMN 💥 catalysts: "We are thrilled to introduce this game-changing technology to the world," said Dr. David Aguilar, Ph.D., SOHM’s COO. "Graphene nanoparticles have the potential to revolutionize genome editing, offering unprecedented precision and efficiency. We believe this breakthrough will have a profound impact on human health and open up new possibilities for scientific research as more gene therapies continue to pass FDA approvals."
View on StockTwits ↗$SHMN 13M+ volume SHMN before 1 hour of trading. Someone loading. Something up. Someone or a group loading. Then 23M shares the other day to .0015. Breaks that 🔑 and it goes 💥
View on StockTwits ↗$SHMN Japenese Pharma talks resumed after patent protection?
View on StockTwits ↗$SHMN Anybody knows what's going on........is there any new contract!?
View on StockTwits ↗$SHMN https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Awarded-European-Patent-for-Innovative-ABBIE-Genome-Editing-Technology?id=475846
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.